State of the art in the endoscopic imaging and ablation of Barrett's esophagus

Digestive and Liver Disease

Volumn 43, Issue 5, 2011, Pages 365-373

  Panossian, Abraham M ^a   Raimondo, Massimo ^a   Wolfsen, Herbert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ablation; Barrett's esophagus; Dysplasia; Endoscopic imaging; Mucosal resection

Indexed keywords

ACETIC ACID; CARBON DIOXIDE; INDIGO CARMINE; METHYLENE BLUE; NITROGEN; PHOTOFRIN;

ABLATION THERAPY; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CHROMOENDOSCOPY; CONFOCAL LASER MICROSCOPY; COST CONTROL; CRYOTHERAPY; DYSPLASIA; EARLY CANCER; ELECTRONICS; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIGHT SCATTERING; MULTIBAND MUCOSECTOMY; NARROW BAND IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL INSTRUMENTATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL TECHNIQUE; WHITE LIGHT ENDOSCOPY;

BARRETT ESOPHAGUS; CATHETER ABLATION; CRYOSURGERY; DISSECTION; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; IMAGE ENHANCEMENT; METAPLASIA; MUCOUS MEMBRANE; PHOTOCHEMOTHERAPY;

EID: 79953271442     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2011.01.011     Document Type: Review

References (95)

1. Van der Veen A.H., Dees J., Blankensteijn J.D., et al. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989, 30:14-18.
2. Goldblum J.R. Barrett's esophagus and Barrett's-related dysplasia. Mod Pathol 2003, 16:316-324.
3. Ormsby A.H., Goldblum J.R., Rice T.W., et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999, 30:288-294.
4. Canto M.I., Kalloo A. Chromoendoscopy for Barrett's esophagus in the twenty-first century: to stain or not to stain?. Gastrointest Endosc 2006, 64:200-205.
5. Canto M.I., Setrakian S., Willis J., et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000, 51:560-568.
6. Canto M.I., Setrakian S., Willis J.E., et al. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Endoscopy 2001, 33:391-400.
7. Kiesslich R., Hahn M., Herrmann G., et al. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 2001, 53:47-52.
8. Kouklakis G.S., Kountouras J., Dokas S.M., et al. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort. Endoscopy 2003, 35:383-387.
9. Ragunath K., Krasner N., Raman V.S., et al. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy 2003, 35:998-1003.
10. Sharma P., Topalovski M., Mayo M.S., et al. Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest Endosc 2001, 54:289-293.
11. Dave U., Shousha S., Westaby D. Methylene blue staining: is it really useful in Barrett's esophagus?. Gastrointest Endosc 2001, 53:333-335.
12. Wo J.M., Ray M.B., Mayfield-Stokes S., et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc 2001, 54:294-301.
13. Gangarosa L.M., Halter S., Mertz H. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia. Dig Dis Sci 2000, 45:225-229.
14. Breyer H.P., Silva De Barros S.G., Maguilnik I., et al. Does methylene blue detect intestinal metaplasia in Barrett's esophagus?. Gastrointest Endosc 2003, 57:505-509.
15. Ngamruengphong S., Sharma V.K., Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc 2009, 69:1021-1028.
16. Olliver J.R., Wild C.P., Sahay P., et al. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003, 362:373-374.
17. Sharma P., Weston A.P., Topalovski M., et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003, 52:24-27.
18. Longcroft-Wheaton G., Duku M., Mead R., et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol H 2010, 8:843-847.
19. Ferguson D., Devault K.R., Loeb D.S., et al. Enhanced magnification directed biopsies do not increase the detection of intestinal metaplasia in patients with GERD. Gastrointest Endosc 2006, 63:Ab234-Ab240.
20. Kara M.A., Ennahachi M., Fockens P., et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc 2006, 64:155-166.
21. Sharma P., Bansal A., Mathur S., et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 2006, 64:167-175.
22. Wolfsen H.C., Crook J.E., Krishna M., et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology 2008, 135:24-31.
23. Sharma P., Bansal A., Hawes R., et al. Detection of metaplasia (IM) and neoplasia in patients with Barrett's esophagus (BE) using high-definition white light endoscopy (HD-WLE) versus narrow band imaging (NBI): a prospective, multi-center, randomized, crossover trial. Gastrointest. Endosc. 2009, 69:Ab135-Ab140.
24. Sharma P., Meining A., Coron E., et al. Detection of neoplastic tissue in Barrett's esophagus with in vivo probe-based confocal endomicroscopy (DONT BIOPCE). Final results of a prospective international RCT: image guided versus 4 quadrant random biopsies?. Gastroenterology 2010, 138:155.
25. Kara M.A., Peters F.P., ten Kate F.J.W., et al. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. Gastrointest Endosc 2005, 61:679-685.
26. Kara M., DaCosta R.S., Wilson B.C., et al. Autofluorescence-based detection of early neoplasia in patients with Barrett's esophagus. Digest Dis 2004, 22:134-141.
27. Niepsuj K., Niepsuj G., Cebula W., et al. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus. Gastrointest Endosc 2003, 58:715-719.
28. Haringsma J., Tytgat G.N.J., Yano H., et al. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 2001, 53:642-650.
29. Kara M.A., Smits M.E., Rosmolen W.D., et al. A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett's esophagus. Gastrointest Endosc 2005, 61:671-678.
30. Borovicka J., Fischer J., Neuweiler J., et al. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy 2006, 38:867-872.
31. Kara M.A., Peters F.P., Fockens P., et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc 2006, 64:176-185.
32. Curvers W.L., Singh R., Song L.M., et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008, 57:167-172.
33. Curvers W.L., Herrero L.A., Wallace M.B., et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology 2010, 139:1106-1114.
34. Neumann H., Kiesslich R., Wallace M.B., et al. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology 2010, 139:388-392. 92 e1-2.
35. Kiesslich R., Gossner L., Goetz M., et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006, 4:979-987.
36. Dunbar K.B., Okolo P., Montgomery E., et al. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc 2009, 70:645-654.
37. Pohl H., Rosch T., Vieth M., et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut 2008, 57:1648-1653.
38. Wallace M.B., Sharma P., Lightdale C., et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc 2010, 72:19-24.
39. Evans J.A., Bouma B.E., Bressner J., et al. Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc 2007, 65:50-56.
40. Poneros J.M., Brand S., Bouma B.E., et al. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 2001, 120:7-12.
41. Isenberg G., Sivak M.V., Chak A., et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointest Endosc 2005, 62:825-831.
42. Evans J.A., Poneros J.M., Bouma B.E., et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 2006, 4:38-43.
43. Suter M.J., Vakoc B.J., Yachimski P.S., et al. Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc 2008, 68:745-753.
44. Suter M.J., Nishioka N.S., Yoo H., et al. Barrett's esophagus screening using balloon-based optical frequency domain imaging: a comparison with endoscopy. Gastrointest Endosc 2010, 71:Ab202-Ab210.
45. Wax A., Terry N.G., Zhu Y.Z., et al. Detection of dysplasia in barrett's esophagus with angle-resolved low coherence interferometry. Gastroenterology 2009, 136:A592-A600.
46. Terry N.G., Zhu Y.Z., Gebhart S.C., et al. Detection of dysplasia in Barrett's esophagus with angle-resolved low coherence interferometry. Gastrointest Endosc 2010, 71. Ab121-Ab2.
47. Siegel M.P., Kim Y.L., Roy H.K., et al. Assessment of blood supply in superficial tissue by polarization-gated elastic light-scattering spectroscopy. Appl Optics 2006, 45:335-342.
48. Wali R.K., Roy H.K., Kim Y.L., et al. Increased microvascular blood content is an early event in colon carcinogenesis. Gut 2005, 54:654-660.
49. Roy H.K., Wali R.K., Kim Y., et al. Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. Febs Lett 2007, 581:3857-3862.
50. Roy H.K., Gomes A., Turzhitsky V., et al. Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk. Gastroenterology 2008, 135:1069-1078.
51. Liu Y., Brand R.E., Turzhitsky V., et al. Optical markers in duodenal mucosa predict the presence of pancreatic cancer. Clin Cancer Res 2007, 13:4392-4399.
52. Morales C.P., Souza R.F., Spechler S.J. Hallmarks of cancer progression in Barrett's oesophagus. Lancet 2002, 360:1587-1589.
53. Karl R.C., Schreiber R., Boulware D., et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000, 231:635-641.
54. Moss A., Bourke M.J., Hourigan L.F., et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010, 105:1276-1283.
55. Waxman I., Konda V.J.A. Mucosal ablation of Barrett esophagus. Nat Rev Gastroenterol 2009, 6:393-401.
56. May A., Gossner L., Behrens A., et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003, 58:167-175.
57. Peters F.R., Kara M.A., Curvers W.L., et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls. Eur J Gastroen Hepat 2007, 19:311-315.
58. Pouw R.E., Gondrie J.J., van Vilsteren F.G., et al. A randomized prospective trial comparing the cap-technique and multi-band mucosectomy technique for piecemeal endoscopic resection in Barrett's esophagus. Eur J Gastroen Hepat 2009, 21:A24-A25.
59. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118:670-677.
60. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroen Hepat 2002, 14:1085-1091.
61. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007, 65:3-10.
62. Chennat J., Konda V.J.A., Ross A.S., et al. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma-an American single-center experience. Am J Gastroenterol 2009, 104:2684-2692.
63. Crespo S.M., Panossian A.M., Wolfsen H.C., et al. Effectiveness of endoscopic mucosal resection alone for treatment of neoplasia in Barrett's esophagus patients. Am J Gastroenterol 2010, 105:S395-Ab.
64. Ciocirlan M., Lapalus M.G., Hervieu V., et al. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 2007, 39:24-29.
65. Esaki M., Matsumoto T., Hirakawa K., et al. Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 2007, 39:41-45.
66. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002, 14:1085-1091.
67. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57:1200-1206.
68. Prasad G.A., Wu T.T., Wigle D.A., et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009, 137:815-823.
69. Ono H. Endoscopic submucosal dissection for early gastric cancer. Chin J Dig Dis 2005, 6:119-121.
70. Oyama T., Tomori A., Hotta K., et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005, 3:S67-70.
71. Fujishiro M., Yahagi N., Nakamura M., et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc 2006, 63:243-249.
72. Cao Y., Liao C., Tan A., et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009, 41:751-757.
73. Fujishiro M., Kodashima S., Goto O., et al. Endoscopic submucosal dissection for esophageal squamous cell neoplasms. Dig Endosc 2009, 21:109-115.
74. Ono S., Fujishiro M., Niimi K., et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009, 70:860-866.
75. Repici A., Hassan C., Carlino A., et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 2010, 71:715-721.
76. Saito Y., Andoh A., Hata K., et al. Chemoradiation Therapy Followed by Endoscopic Submucosal Dissection for Esophageal Cancer. Digest Dis Sci 2008, 53:3242-3245.
77. Saito Y., Takisawa H., Suzuki H., et al. Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. Gastrointest Endosc 2008, 67:355-359.
78. Yoshinaga S., Gotoda T., Kusano C., et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 2008, 67:202-209.
79. Ikeda K., Isomoto H., Oda H., et al. Endoscopic submucosal dissection of a minute intramucosal adenocarcinoma in Barrett's esophagus. Dig Endosc 2009, 21:34-36.
80. Wolfsen H.C. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 2005, 39:653-664.
81. Wolfsen H.C. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol 2005, 39:189-202.
82. Prasad G.A., Wang K.K., Baron T.H., et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 2007, 5:743-748.
83. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62:488-498.
84. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007, 132:1226-1233.
85. Panjehpour M., Overholt B.F. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers Surg Med 2006, 38:390-395.
86. Wolfsen H.C. Endoluminal therapy for esophageal disease: an introduction. Gastrointest Endosc Clin N Am 2010, 20:1-10. v.
87. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-2288.
88. Van Vilsteren F.B.J. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus. Gastrointest Endoscopy Clin N Am 2010, 20.
89. Fleischer D.E., Odze R., Overholt B.F., et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Digest Dis Sci 2010, 55:1918-1931.
90. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic radiofrequency ablation for barrett's esophagus: five-year durability outcomes from a prospective multi-center trial. Gastrointest Endosc 2010, 71:Ab117-Ab118.
91. Falk G.W. Radiofrequency ablation of Barrett's esophagus: let's not get ahead of ourselves (vol. 55, p. 1811, 2010). Digest Dis Sci 2010, 55. p. 3011.
92. Halsey K.D., Greenwald B.D. Cryotherapy in the management of esophageal dysplasia and malignancy. Gastrointest Endosc Clin N Am 2010, 20:75-87. vi-vii.
93. Shaheen N.J., Greenwald B.D., Peery A.F., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010, 71:680-685.
94. Dumot J.A., Vargo J.J., Falk G.W., et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 2009, 70:635-644.
95. 2) cryotherapy is a safe and effective treatment of Barrett's esophagus (BE) with HGD/intramucosal carcinoma. Gastrointest Endosc 2009, 69. Ab341-Ab.